Thoughtful use of real-world evidence (RWE) has the power to revolutionise patient safety, clinical standards, and drive-up cost efficiencies, which is why it has become a priority for the medical and pharmaceutical profession.
RWE is the clinical evidence regarding the usage and potential benefits, or risks of a medicine or device derived from the analysis of the data collected on how it’s being used, or is performing, in a large-scale real-world setting. RWE answers the question of how well a medicine or device works in an average clinical or real-world environment.
Leveraging RWE will provide more timely access to broader and richer sets of information, and it’s increasingly being touted and acknowledged as a gamechanger in product research and development.1
Although randomised controlled trials (RCTs) remain the gold standard of scientific evidence, there is growing clamour for a more broad-based approach to accruing scientif